SWE to Detect Enthesitis in PsA: Relationship With SIRT2 Expression and Disease Activity

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

1. To assess the diagnostic utility of shear-wave elastography (SWE), gray-scale (GS) ultrasound, and Power Doppler (PD) in detecting Patellar and Achilles tendinopathy in psoriatic patients with and without arthritis. 2. Investigate the relation between SWE, GS ultrasound, and PD finding and SIRT2 expression levels. 3. Evaluate the association of the imaging findings and SIRT2 levels with psoriatic arthritis disease activity score.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients diagnosed as PsO by a dermatologist according to PASI score.

Patients diagnosed as PsA by rheumatologist according to CASPAR classification criteria for psoriatic arthritis

Adult patients of both sexes with an average > 18 years

Disqualifiers

Patients with a history of metabolic disease affecting tendons.

Patients with history of surgery, injury or trauma of patellar and/or Achilles tendon.

Patients with other rheumatological diseases.

Patients below 18.

Trial population

57 participants: 19 Psoriatic arthritis patients, 19 Psoriasis-only patients and 19 healthy control.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Musculoskeletal Ultrasound Device

    Device

    Musculoskeletal Ultrasound assessment by LOGIQ P10 from General Electric (GE) Healthcare, each patient will be evaluated by grey scale, power doppler MSUS and Shear Wave Elastography (SWE)

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Assessment and comparting the diagnostic utility of shear-wave elastography (SWE) , Gray-scale (GS) ultrasound. and Power Doppler (PD) in detecting tendinopathy in psoriatic patients with and without arthritis.

Musculoskeletal Ultrasound assessment by LOGIQ P10 from General Electric (GE) Healthcare, a division of General Electric Company

Time frame
At baseline (single study visit)

Secondary outcomes

1

Investigate the correlation between SWE, GS ultrasound and PD finding and SIRT2 expression levels and evaluate the correlation of the imaging finding and SIRT2 levels with psoriatic arthritis disease activity score (PASDAS).

Time frame
At baseline (single study visit)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: